Global Growth Props Up Pfizer’s Chantix Against U.S. Decline

Pfizer released its second-quarter earnings this morning, and the Health Blog rushed to see what happened with Chantix. The smoking-cessation drug, which quickly became popular after it went on the market in 2006, has come under scrutiny in recent months as psychiatric side effects and other possible problems were linked to the drug. That worries [...]